id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0915-0007,FDA,FDA-2011-N-0915,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application,Notice,60 Day Proposed Information Collection,2018-08-15T04:00:00Z,2018,8,2018-08-15T04:00:00Z,2018-10-16T03:59:59Z,2018-10-17T01:01:01Z,2018-17526,0,0,090000648362232f
FDA-2011-N-0915-0006,FDA,FDA-2011-N-0915,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Guidance for Industry on
Postmarketing Adverse Event Reporting for Nonprescription Human
Drug Products Marketed Without an Approved Application",Notice,Notice of Approval,2016-02-03T05:00:00Z,2016,2,2016-02-03T05:00:00Z,,2016-02-03T15:15:15Z,2016-01885,0,0,0900006481e49f43
FDA-2011-N-0915-0004,FDA,FDA-2011-N-0915,"Agency Information Collection Activities; Proposed Collection;
Submission for Office of Management and Budget Review; Guidance for
Industry on Postmarketing Adverse Event Reporting for Nonprescription
Human Drug Products Marketed Without an Approved Application",Notice,30 Day Proposed Information Collection,2015-06-25T04:00:00Z,2015,6,2015-06-25T04:00:00Z,2015-07-28T03:59:59Z,2015-06-25T13:48:52Z,2015-15638,0,0,0900006481b54bc8
FDA-2011-N-0915-0003,FDA,FDA-2011-N-0915,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Guidance for Industry on Postmarketing Adverse
Event Reporting for Nonprescription Human Drug Products Marketed
Without an Approved Application",Notice,60 Day Proposed Information Collection,2015-01-23T05:00:00Z,2015,1,2015-01-23T05:00:00Z,2015-03-25T03:59:59Z,2015-03-24T02:04:49Z,2015-01111,0,0,09000064819db747
FDA-2011-N-0915-0002,FDA,FDA-2011-N-0915,Agency Information Collection Activities; Submissions for Office Management and Budget Review; Comment Request; Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application,Notice,General Notice,2012-05-24T04:00:00Z,2012,5,,,2012-05-24T15:47:25Z,2012-12589,0,0,090000648101b320
FDA-2011-N-0915-0001,FDA,FDA-2011-N-0915,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products, etc.",Notice,General Notice,2011-12-27T05:00:00Z,2011,12,2011-12-27T05:00:00Z,2012-02-28T04:59:59Z,2011-12-27T16:45:58Z,2011-33140,0,0,0900006480f89156